Total Revenue |
377.27B |
319.66B |
302.21B |
310.65B |
Cost of Revenue |
187.55B |
146.04B |
149.82B |
149.7B |
Gross Profit |
189.72B |
173.62B |
152.39B |
160.95B |
Operating Expenses |
95.4B |
114.86B |
110.37B |
110.51B |
Research and Development |
949.7M |
0 |
0 |
0 |
Selling, General & Administrative Expenses |
95.4B |
38.57B |
37.4B |
43.2B |
Selling & Marketing Expenses |
49.06B |
38.57B |
37.4B |
43.2B |
General & Administrative Expenses |
46.33B |
0 |
0 |
0 |
Other Expenses |
4.27B |
-19.71B |
-9.38B |
-12.46B |
Operating Income |
94.33B |
39.04B |
32.6B |
51.74B |
Total Other Income/Expenses Net |
-55.98B |
-44.05B |
-31.69B |
-32.78B |
Income Before Tax |
38.35B |
34.72B |
28.62B |
34.38B |
Income Tax |
12.07B |
8.68B |
8.38B |
8.62B |
Net Income |
13.7B |
15.14B |
11.64B |
15.76B |
Basic EPS |
20.69 |
22.98 |
17.6 |
23.92 |
EPS Diluted |
20.65 |
22.96 |
17.6 |
23.89 |
Basic Average Shares |
661.08M |
661.08M |
661.08M |
661.08M |
Diluted Average Shares |
661.08M |
661.08M |
661.08M |
661.08M |
EBITDA |
77.5B |
71.5B |
63.37B |
66.53B |